Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors

Enrique de Álava

DOI: https://doi.org/10.1007/s00428-024-03736-5

2024-01-18

Virchows Archiv

Abstract:This review shows the extraordinary change molecular pathology has induced in the classification, diagnosis, and clinical practice of molecular pathologists dealing with sarcomas. We have primarily focused on the practical aspects of molecular studies and the current and mid-term challenges for our subspecialty, ending with ten tips for the next generation of sarcoma molecular pathologists.

pathology

What problem does this paper attempt to address?

The paper attempts to address issues primarily focused on the challenges and practical aspects of applying molecular pathology in the diagnosis and clinical practice of bone and soft tissue tumors. Specifically:

1. **Challenges in Classification and Diagnosis**:
- The development of molecular pathology has significantly changed the classification, diagnosis, and clinical practice of bone and soft tissue tumors.
- The paper focuses on the practical application of molecular research and the challenges faced currently and in the mid-term.

2. **Role of Molecular Pathology in Tumor Biology**:
- Molecular pathology has revolutionized our understanding of tumor biology, especially regarding the natural history of mesenchymal neoplasms.
- Different types of mesenchymal tumors have distinct molecular characteristics, which are significant for diagnosis and treatment.

3. **Specific Types of Tumors and Their Molecular Characteristics**:
- The paper details the molecular characteristics of different types of soft tissue and bone tumors, including lipogenic tumors, fibrous and myofibrous tumors, fibrohistiocytic tumors, vascular tumors, smooth muscle tumors, rhabdomyosarcomas, osteochondrogenic tumors, nerve sheath tumors, and other soft tissue tumors.
- Specific molecular markers and gene mutations for each type of tumor are described in detail, such as MDM2 and CDK4 gene amplification in lipogenic tumors, and NCOA2 gene rearrangement in fibrohistiocytic tumors.

4. **Application of Molecular Diagnostic Techniques**:
- The application and limitations of traditional molecular diagnostic techniques such as karyotyping, comparative genomic hybridization (CGH), fluorescence in situ hybridization (FISH), and polymerase chain reaction (PCR) in diagnosis.
- Advances in modern molecular diagnostic techniques such as next-generation sequencing (NGS), NanoString, untargeted large-scale sequencing, and methylation studies, and their application in clinical practice.

5. **Recommendations for Molecular Pathology in Clinical Practice**:
- Integrating molecular test results within the clinical and pathological context.
- Recommending the use of traditional techniques for basic evaluation, followed by modern techniques for advanced analysis.
- Emphasizing that molecular pathology should serve as an auxiliary tool, combined with histopathology, to improve diagnostic accuracy and specificity.

6. **Current Challenges**:
- Handling discrepancies between results from different molecular techniques.
- Pre-analytical challenges, particularly the impact of the decalcification process on nucleic acid quality in bone tumors.
- Ensuring the widespread and equitable distribution of advanced molecular testing tools within the healthcare system.

In summary, the paper aims to comprehensively explore the current status, challenges, and future directions of applying molecular pathology in the diagnosis and clinical practice of bone and soft tissue tumors, providing practical guidance for the new generation of molecular pathologists.